Go to deals
Healthcare

Lenmed Health Management Pty Ltd has acquired Daxina Medical Center (DMC)

Lenmed Health Pty Ltd, through its subsidiary Lenmed Health Management Pty Ltd. (Lenmed Health), has acquired the business assets of Daxina Medical Center (DMC), comprising the hospital land and buildings and all other assets and operations of the hospital, including the pharmacy assets and operations located on the land from which DMC conducts its hospital activities, for US$5.5 million.

Lenmed Health is an established hospital group in South Africa, operating multi-specialty hospital facilities in South Africa, Mozambique and Botswana, managing more than 1,300 beds.

DMC is a 100% private hospital located south of Johannesburg to serve the communities of Lenasia South, Orange Farm, Ennerdale, Evaton, Sebokeng and Vereeniging.

Oaklins' team in South Africa acted as corporate and financial advisor to the buyer in this transaction.

Parties

Talk to the deal team

Yaron Zimbler

Director
Johannesburg, South Africa
Oaklins African Bank

Related deals

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.
Healthcare

Dimainvest S.r.l. has launched a voluntary public tender offer for Shedir Pharma Group S.p.A.

Dimainvest S.r.l. has initiated a voluntary public tender offer for the shares of Shedir Pharma Group S.p.A.

Learn more
Afric Phar has been acquired by Pharma Capital
Healthcare

Afric Phar has been acquired by Pharma Capital

Pharma Capital S.A. has acquired a significant stake in the Moroccan pharmaceutical group Afric Phar, which includes leading companies Afric Phar, Pharmis and Partner Lab, from the Chaoui family, in one of the largest transactions in the Moroccan pharmaceutical sector.

Learn more
Xiel Limited has been acquired by MIS Healthcare
Private Equity | Healthcare

Xiel Limited has been acquired by MIS Healthcare

MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.

Learn more